Former Procter & Gamble Employees Develop New Drug for Blue Ash Therapeutics, Inc., Gain $2 Million in Startup Funds

Published: Apr 27, 2010

Soapbox -- Procter & Gamble may have exited the pharmaceutical making business but some of the talent behind its drug development continues to create in Cincinnati. Blue Ash Pharmaceuticals, a startup, is on the verge of a major breakthrough with $2 million in recently secured financing and a new heart-related drug in the final stages of FDA approval.

Back to news